Cargando…
Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
AIM AND OBJECTIVE: Weekly administration of cisplatin (cis-diamminedichloroplatinum [CDDP]) appears more feasible and substantially more popular than the 3 weekly schedules due to better compliance. Different concurrent cisplatin schedules have been attempted including a daily schedule. We did a com...
Autores principales: | Gupta, Pramod Kumar, Lal, Punita, Bajpai, Ranjeet, Goel, Anshu, Yadav, Rajan, Verma, Mranalini, Kumar, Shaleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873705/ https://www.ncbi.nlm.nih.gov/pubmed/27275456 http://dx.doi.org/10.4103/2278-330X.181647 |
Ejemplares similares
-
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
por: Nanda, R., et al.
Publicado: (2019) -
The impact of 2 weeks wait referral on survival of head and neck cancer patients
por: Rovira, Aleix, et al.
Publicado: (2023) -
Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
por: Nair, Lekha Madhavan, et al.
Publicado: (2017) -
Use of PerClot(®) in head and neck surgery: a Scottish centre experience
por: Rao, Kanishka, et al.
Publicado: (2020) -
Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program
por: Cnossen, Ingrid C., et al.
Publicado: (2016)